| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
COLUMBUS, Ga. & PISCATAWAY, N.J.—At the end of January, IACT Health, a clinical trial management company dedicated to streamlining study operations for highly efficient clinical trials, and Alpha Clinical Systems, a provider of affordable and comprehensive next-generation e-source solutions, announced that IACT Health has selected Alpha Clinical Systems’ ACS360 e-source platform for clinical trial data capture.
 
Alpha Clinical Systems will provide the fully integrated ACS360 platform, including Study Designer and ez-SourceDocx. Using the ACS360 platform, IACT Health will streamline study startup and execution with web-based study design and tablet-based direct e-source data capture. The ACS360 platform is designed to help streamline study operations by providing truly paperless data capture and real-time access to validated study data, dramatically reducing study timelines and costs.
 
“IACT Health is excited to begin working with Alpha Clinical Systems in an effort to further streamline study operations via their next-generation ACS360 e-source platform,” said Christine Senn, chief information officer of IACT Health. “We selected the ACS360 platform because we required an e-source solution that was both comprehensive and affordable, and could deliver real-time, remote access to high-quality study data.”
 
“IACT Health required a more comprehensive, yet affordable, e-source solution that would streamline and modernize their clinical trials,” added Murthy Gandham, CEO of Alpha Clinical Systems. “We look forward to helping IACT Health deliver high-quality data in real-time via the ACS360 platform.”
 
Alpha Clinical Systems developed the ACS360 platform to eliminate the challenges of e-source adoption among life-sciences companies. Designed to maximize site efficiency and data quality, the ACS360 platform works with or without existing electronic data capture systems to deliver real-time, remote access to validated clinical trial data.

Related Topics

Published In

Volume 14 - Issue 3 | March 2018

March 2018

March 2018 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
A starry night sky reflected over calm water, symbolizing the discovery of hidden patterns in complex systems.

Technology Guide: Spatial biology techniques

Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue